Pharmaceutical price gouging: Capitalism never sleeps.
The Turing company and its overpriced drug, Daraprim, is just one case of thousands over the years pointing to exactly the same thing: the profit motive must be extirpated, ripped out, from the core of the American healthcare system. Only in America do so many people take a situation so morbidly and obviously wrong —and often callously criminal—with such level of acceptance and passivity. —PG
Turing Pharmaceuticals CEO defends Daraprim price hike
When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the movie is simply a smart business decision.
Nauseated by the
vile corporate media?
Had enough of their lies, escapism,
omissions and relentless manipulation?
Send a donation to
The Greanville Post–or
But be sure to support YOUR media.
If you don’t, who will?
